dc.contributor.author
Böge, Kerem
dc.contributor.author
Schaeuffele, Carmen
dc.contributor.author
Jacobsen, Pamela
dc.contributor.author
Chadwick, Paul
dc.contributor.author
Ergen, Emre
dc.contributor.author
Hahne, Inge
dc.contributor.author
Bergmann, Niklas
dc.contributor.author
Boettcher, Johanna
dc.contributor.author
Wingenfeld, Katja
dc.contributor.author
Bajbouj, Malek
dc.contributor.author
Hahn, Eric
dc.date.accessioned
2022-09-09T09:07:02Z
dc.date.available
2022-09-09T09:07:02Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/36237
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-35953
dc.description.abstract
Objectives: The aim of the study was to assess the convergent and divergent validity, reliability, utility, and treatment sensitivity of a newly translated German version of the Southampton Mindfulness Questionnaire (SMQ). The SMQ is a 16-item instrument measuring mindful awareness of distressing thoughts, images, and perceptions, developed originally within the mindfulness for psychosis field.
Methods: Overall, three studies were conducted, comprising (1) a non-clinical sample of n = 848 (638 community sample and 210 meditators); (2) a clinical sample of n = 213 (106 schizophrenia and 107 depression); and (3) a clinical sample with n = 122 participants with emotional disorders within a randomized controlled study, of which 30 participants were also included in study 2. To assess convergent validity, participants completed the SMQ, Freiburg Mindfulness Inventory (FMI), and Comprehensive Inventory of Mindfulness Experiences (CHIME). To measure divergent validity, participants completed the Brief Symptom Inventory 18 (BSI-18), Positive and Negative Affect Schedule (PANAS), Brief Experiential Avoidance Questionnaires (BEAQ), and Anxiety Sensitivity Index 3 (ASI-3).
Results: Mean internal consistency (α = 0.89) and convergent (r = 0.66 to 0.73) and divergent validity (r = − 0.09 to − 0.50) were established and sensitivity to change over time following treatment (d = 0.86) was shown. For the clinical sample, a single-factor structure is suggested by principal component analysis.
Conclusions: Results provide first evidence for the utility of the German version of the SMQ for clinical practice and research in healthy individuals, meditators, and clinical groups. Further research is needed to examine the underlying construct of mindfulness.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Southampton Mindfulness Questionnaire
en
dc.subject
Schizophrenia
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Validation of the German Version of the Southampton Mindfulness Questionnaire (SMQ)
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s12671-020-01447-x
dcterms.bibliographicCitation.journaltitle
Mindfulness
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
2219
dcterms.bibliographicCitation.pageend
2234
dcterms.bibliographicCitation.volume
11
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.issn
1868-8527
dcterms.isPartOf.eissn
1868-8535